Development of off-the-shelf hematopoietic stem
cell-engineered invariant natural killer T cells for
COVID-19 therapeutic intervention
V-SYNTHES 2.0 – A New Approach for the Screening
Giga-Scale Space in Computer-aided Drug Design
and Its Usefulness in Finding Novel Therapeutics
Against Acute Respiratory Distress Syndrome
Caused by COVID-19